{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:03:20Z","timestamp":1762452200900,"version":"build-2065373602"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ubon Ratchathani University, Thailand"},{"name":"Fundamental Fund of Khon Kaen University under the National Science, Research and Innovation Fund, Thailand"},{"name":"NSRF via the Program Management Unit for Human Resources & Institutional Development, Research and Innovation, Thailand","award":["B38G670003"],"award-info":[{"award-number":["B38G670003"]}]},{"name":"Visiting Professor Scholar under BCG Economy and Sustainable Development Network through Center of Excellence Consortium, Khon Kaen University, Thailand"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10822-025-00602-7","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T06:13:19Z","timestamp":1747635199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting multiple pathways with virtual screening to identify the multi-target agent for Alzheimer\u2019s disease treatment"],"prefix":"10.1007","volume":"39","author":[{"given":"Pitchayakarn","family":"Takomthong","sequence":"first","affiliation":[]},{"given":"Pornthip","family":"Waiwut","sequence":"additional","affiliation":[]},{"given":"Chantana","family":"Boonyarat","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"602_CR1","volume-title":"Alzheimer disease","author":"A Kumar","year":"2024","unstructured":"Kumar A, Sidhu J, Lui F, Tsao JW (2024) Alzheimer disease. In: StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"key":"602_CR2","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.3390\/molecules25245789","volume":"25","author":"Z Breijyeh","year":"2020","unstructured":"Breijyeh Z, Karaman R (2020) Comprehensive review on Alzheimer\u2019s disease: causes and treatment. Molecules 25:5789. https:\/\/doi.org\/10.3390\/molecules25245789","journal-title":"Molecules"},{"key":"602_CR3","doi-asserted-by":"publisher","first-page":"115522","DOI":"10.1016\/j.bcp.2023.115522","volume":"211","author":"AR Monteiro","year":"2023","unstructured":"Monteiro AR, Barbosa DJ, Remi\u00e3o F, Silva R (2023) Alzheimer\u2019s disease: insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs. Biochem Pharmacol 211:115522. https:\/\/doi.org\/10.1016\/j.bcp.2023.115522","journal-title":"Biochem Pharmacol"},{"doi-asserted-by":"crossref","unstructured":"Peng Y, Jin H, Xue Y et al (2023) Current and future therapeutic strategies for Alzheimer\u2019s disease: an overview of drug development bottlenecks. Front Aging Neurosci 15","key":"602_CR4","DOI":"10.3389\/fnagi.2023.1206572"},{"key":"602_CR5","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K et al (2021) The Amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Mol Psychiatry 26:5481\u20135503. https:\/\/doi.org\/10.1038\/s41380-021-01249-0","journal-title":"Mol Psychiatry"},{"key":"602_CR6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3233\/JAD-2010-1221","volume":"19","author":"MP Murphy","year":"2010","unstructured":"Murphy MP, LeVine H (2010) Alzheimer\u2019s disease and the amyloid-beta peptide. J Alzheimers Dis 19:311\u2013323. https:\/\/doi.org\/10.3233\/JAD-2010-1221","journal-title":"J Alzheimers Dis"},{"key":"602_CR7","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.tips.2024.05.005","volume":"45","author":"B Turgutalp","year":"2024","unstructured":"Turgutalp B, Kizil C (2024) Multi-target drugs for Alzheimer\u2019s disease. Trends Pharmacol Sci 45:628\u2013638. https:\/\/doi.org\/10.1016\/j.tips.2024.05.005","journal-title":"Trends Pharmacol Sci"},{"key":"602_CR8","doi-asserted-by":"publisher","first-page":"101380","DOI":"10.1016\/j.imu.2023.101380","volume":"43","author":"I Ahammad","year":"2023","unstructured":"Ahammad I, Chowdhury ZM, Bhattacharjee A et al (2023) Structure-based Pharmacological screening, molecular Docking and dynamic simulation reveals dexketoprofen as a repurposable drug against Alzheimer\u2019s disease. Inf Med Unlocked 43:101380. https:\/\/doi.org\/10.1016\/j.imu.2023.101380","journal-title":"Inf Med Unlocked"},{"key":"602_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.12982\/BSCM.2024.21","volume":"63","author":"P Takomthong","year":"2024","unstructured":"Takomthong P, Waiwut P, Ballatore C et al (2024) High-throughput virtual Screening- and molecular Docking-based prediction for acetylcholinesterase inhibitors and exploring its mechanisms against Alzheimer\u2019s disease based on network Pharmacology. BSCM 63:183\u2013197. https:\/\/doi.org\/10.12982\/BSCM.2024.21","journal-title":"BSCM"},{"key":"602_CR10","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"key":"602_CR11","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3390\/ph14090888","volume":"14","author":"P Takomthong","year":"2021","unstructured":"Takomthong P, Waiwut P, Yenjai C et al (2021) Multi-Target actions of acridones from Atalantia monophylla towards Alzheimer\u2019s pathogenesis and their Pharmacokinetic properties. Pharmaceuticals 14:888. https:\/\/doi.org\/10.3390\/ph14090888","journal-title":"Pharmaceuticals"},{"key":"602_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jmgm.2012.11.008","volume":"39","author":"S-G Chen","year":"2013","unstructured":"Chen S-G, Gu R-X, Dai H, Wei D-Q (2013) Virtual screening for alpha7 nicotinic acetylcholine receptor for treatment of Alzheimer\u2019s disease. J Mol Graph Model 39:98\u2013107. https:\/\/doi.org\/10.1016\/j.jmgm.2012.11.008","journal-title":"J Mol Graph Model"},{"key":"602_CR13","doi-asserted-by":"publisher","first-page":"e21894","DOI":"10.1016\/j.heliyon.2023.e21894","volume":"9","author":"PN Arsito","year":"2023","unstructured":"Arsito PN, Waiwut P, Yenjai C et al (2023) Multifunctional effect of flavonoids from Millettia brandisiana against Alzheimer\u2019s disease pathogenesis. Heliyon 9:e21894. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21894","journal-title":"Heliyon"},{"key":"602_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman GL, Courtney KD, Andres V, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88\u201395. https:\/\/doi.org\/10.1016\/0006-2952(61)90145-9","journal-title":"Biochem Pharmacol"},{"key":"602_CR15","doi-asserted-by":"publisher","first-page":"5892","DOI":"10.1074\/jbc.M404751200","volume":"280","author":"F Yang","year":"2005","unstructured":"Yang F, Lim GP, Begum AN et al (2005) Curcumin inhibits formation of amyloid \u0392 oligomers and fibrils, binds plaques, and reduces amyloid in vivo**. J Biol Chem 280:5892\u20135901. https:\/\/doi.org\/10.1074\/jbc.M404751200","journal-title":"J Biol Chem"},{"key":"602_CR16","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.3390\/cimb45050259","volume":"45","author":"K Plekratoke","year":"2023","unstructured":"Plekratoke K, Boonyarat C, Monthakantirat O et al (2023) The effect of ethanol extract from mesua Ferrea Linn flower on Alzheimer\u2019s disease and its underlying mechanism. Curr Issues Mol Biol 45:4063\u20134079. https:\/\/doi.org\/10.3390\/cimb45050259","journal-title":"Curr Issues Mol Biol"},{"key":"602_CR17","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1021\/acs.jcim.3c01053","volume":"63","author":"M Bugnon","year":"2023","unstructured":"Bugnon M, Goullieux M, R\u00f6hrig UF et al (2023) SwissParam 2023: A modern Web-Based tool for efficient small molecule parametrization. J Chem Inf Model 63:6469\u20136475. https:\/\/doi.org\/10.1021\/acs.jcim.3c01053","journal-title":"J Chem Inf Model"},{"key":"602_CR18","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1002\/fsn3.2956","volume":"10","author":"L Zolghadr","year":"2022","unstructured":"Zolghadr L, Behbehani GR, PakBin B et al (2022) Molecular dynamics simulations, molecular docking, and kinetics study of Kaempferol interaction on Jack bean urease: comparison of extended solvation model. Food Sci Nutr 10:3585\u20133597. https:\/\/doi.org\/10.1002\/fsn3.2956","journal-title":"Food Sci Nutr"},{"key":"602_CR19","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1021\/ci3001277","volume":"52","author":"JJ Irwin","year":"2012","unstructured":"Irwin JJ, Sterling T, Mysinger MM et al (2012) ZINC: A free tool to discover chemistry for biology. J Chem Inf Model 52:1757\u20131768. https:\/\/doi.org\/10.1021\/ci3001277","journal-title":"J Chem Inf Model"},{"key":"602_CR20","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.drudis.2013.02.008","volume":"18","author":"I Yusof","year":"2013","unstructured":"Yusof I, Segall MD (2013) Considering the impact drug-like properties have on the chance of success. Drug Discovery Today 18:659\u2013666. https:\/\/doi.org\/10.1016\/j.drudis.2013.02.008","journal-title":"Drug Discovery Today"},{"key":"602_CR21","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1021\/mp400170b","volume":"10","author":"LA Khawli","year":"2013","unstructured":"Khawli LA, Prabhu S (2013) Drug delivery across the Blood\u2013Brain barrier. Mol Pharm 10:1471\u20131472. https:\/\/doi.org\/10.1021\/mp400170b","journal-title":"Mol Pharm"},{"key":"602_CR22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1124\/pr.107.07109","volume":"60","author":"DS Miller","year":"2008","unstructured":"Miller DS, Bauer B, Hartz AMS (2008) Modulation of P-glycoprotein at the Blood-Brain barrier: opportunities to improve CNS pharmacotherapy. Pharmacol Rev 60:196\u2013209. https:\/\/doi.org\/10.1124\/pr.107.07109","journal-title":"Pharmacol Rev"},{"key":"602_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/bmb.2006.49403402066","volume":"34","author":"LL Furge","year":"2006","unstructured":"Furge LL, Guengerich FP (2006) Cytochrome P450 enzymes in drug metabolism and chemical toxicology: an introduction. Biochem Mol Biol Educ 34:66\u201374. https:\/\/doi.org\/10.1002\/bmb.2006.49403402066","journal-title":"Biochem Mol Biol Educ"},{"doi-asserted-by":"publisher","unstructured":"Jasiecki J, Targo\u0144ska M, Was\u0105g B (2021) The role of butyrylcholinesterase and Iron in the regulation of cholinergic network and cognitive dysfunction in Alzheimer\u2019s disease pathogenesis. Int J Mol Sci 22(2033). https:\/\/doi.org\/10.3390\/ijms22042033","key":"602_CR24","DOI":"10.3390\/ijms22042033"},{"key":"602_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1017\/S1461145705005833","volume":"9","author":"RM Lane","year":"2006","unstructured":"Lane RM, Potkin SG, Enz A (2006) Targeting acetylcholinesterase and butyrylcholinesterase in dementia. Int J Neuropsychopharmacol 9:101\u2013124. https:\/\/doi.org\/10.1017\/S1461145705005833","journal-title":"Int J Neuropsychopharmacol"},{"key":"602_CR26","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.2174\/1871527313666141023141545","volume":"13","author":"G Mushtaq","year":"2014","unstructured":"Mushtaq G, Greig NH, Khan JA, Kamal MA (2014) Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer\u2019s disease and type 2 diabetes mellitus. CNS Neurol Disord Drug Targets 13:1432\u20131439","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"602_CR27","doi-asserted-by":"publisher","first-page":"5147","DOI":"10.1021\/cr3000994","volume":"112","author":"IW Hamley","year":"2012","unstructured":"Hamley IW (2012) The amyloid beta peptide: a chemist\u2019s perspective. Role in Alzheimer\u2019s and fibrillization. Chem Rev 112:5147\u20135192. https:\/\/doi.org\/10.1021\/cr3000994","journal-title":"Chem Rev"},{"key":"602_CR28","doi-asserted-by":"publisher","first-page":"a006387","DOI":"10.1101\/cshperspect.a006387","volume":"2","author":"D Schenk","year":"2012","unstructured":"Schenk D, Basi GS, Pangalos MN (2012) Treatment strategies targeting amyloid \u03b2-Protein. Cold Spring Harb Perspect Med 2:a006387. https:\/\/doi.org\/10.1101\/cshperspect.a006387","journal-title":"Cold Spring Harb Perspect Med"},{"key":"602_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.7164\/antibiotics.27.65","volume":"27","author":"T Hayashi","year":"1974","unstructured":"Hayashi T, Takatsuki A, Tamura G (1974) The action mechanism of Brefeldin A. J Antibiot 27:65\u201372. https:\/\/doi.org\/10.7164\/antibiotics.27.65","journal-title":"J Antibiot"},{"key":"602_CR30","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1021\/jm0602817","volume":"49","author":"NO Anadu","year":"2006","unstructured":"Anadu NO, Davisson VJ, Cushman M (2006) Synthesis and anticancer activity of Brefeldin A ester derivatives. J Med Chem 49:3897\u20133905. https:\/\/doi.org\/10.1021\/jm0602817","journal-title":"J Med Chem"},{"key":"602_CR31","doi-asserted-by":"publisher","first-page":"105388","DOI":"10.1016\/j.arabjc.2023.105388","volume":"17","author":"Y Bai","year":"2024","unstructured":"Bai Y, Ren D, Xue X et al (2024) Structurally diverse Brefeldin A derivatives as potent and selective acetylcholinesterase inhibitors from an endophytic fungus Penicillium brefeldianum F4a. Arab J Chem 17:105388. https:\/\/doi.org\/10.1016\/j.arabjc.2023.105388","journal-title":"Arab J Chem"},{"key":"602_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.neurobiolaging.2019.12.009","volume":"89","author":"T Hamano","year":"2020","unstructured":"Hamano T, Shirafuji N, Yen S-H et al (2020) Rho-kinase ROCK inhibitors reduce oligomeric Tau protein. Neurobiol Aging 89:41\u201354. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.12.009","journal-title":"Neurobiol Aging"},{"key":"602_CR33","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.3390\/cells12101367","volume":"12","author":"EJ Glotfelty","year":"2023","unstructured":"Glotfelty EJ, Tovar-y-Romo LB, Hsueh S-C et al (2023) The RhoA-ROCK1\/ROCK2 pathway exacerbates inflammatory signaling in immortalized and primary microglia. Cells 12:1367. https:\/\/doi.org\/10.3390\/cells12101367","journal-title":"Cells"},{"key":"602_CR34","doi-asserted-by":"publisher","first-page":"e13001","DOI":"10.1111\/acel.13001","volume":"18","author":"Y Hu","year":"2019","unstructured":"Hu Y, Ren R, Zhang Y et al (2019) Rho-associated coiled\u2010coil kinase 1 activation mediates amyloid precursor protein site\u2010specific Ser655 phosphorylation and triggers amyloid pathology. Aging Cell 18:e13001. https:\/\/doi.org\/10.1111\/acel.13001","journal-title":"Aging Cell"},{"key":"602_CR35","doi-asserted-by":"publisher","first-page":"4812","DOI":"10.3390\/ijms21134812","volume":"21","author":"Y Akwa","year":"2020","unstructured":"Akwa Y (2020) Steroids and Alzheimer\u2019s disease: changes associated with pathology and therapeutic potential. IJMS 21:4812. https:\/\/doi.org\/10.3390\/ijms21134812","journal-title":"IJMS"},{"key":"602_CR36","doi-asserted-by":"publisher","first-page":"109468","DOI":"10.1016\/j.steroids.2024.109468","volume":"209","author":"PP Pandey","year":"2024","unstructured":"Pandey PP, Kumar MS (2024) Exploring the therapeutic potential of steroidal alkaloids in managing Alzheimer\u2019s disease. Steroids 209:109468. https:\/\/doi.org\/10.1016\/j.steroids.2024.109468","journal-title":"Steroids"},{"key":"602_CR37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/978-3-211-99390-3_39","volume-title":"Functional ultrastructure: atlas of tissue biology and pathology","author":"M Pavelka","year":"2010","unstructured":"Pavelka M, Roth J (2010) Brefeldin A-Induced golgi apparatus disassembly. In: Pavelka M, Roth J (eds) Functional ultrastructure: atlas of tissue biology and pathology. Springer, Vienna, pp 74\u201375"},{"key":"602_CR38","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.neurobiolaging.2013.11.022","volume":"35","author":"Q Jiang","year":"2014","unstructured":"Jiang Q, Wang L, Guan Y et al (2014) Golgin-84-associated golgi fragmentation triggers Tau hyperphosphorylation by activation of cyclin-dependent kinase-5 and extracellular signal-regulated kinase. Neurobiol Aging 35:1352\u20131363. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.11.022","journal-title":"Neurobiol Aging"},{"doi-asserted-by":"crossref","unstructured":"Grundke-Iqbal I, Iqbal K, Tung YC, et al (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 83:4913\u20134917.","key":"602_CR39","DOI":"10.1073\/pnas.83.13.4913"},{"doi-asserted-by":"publisher","unstructured":"Joshi G, Bekier M, Wang Y (2015) Golgi Fragmentation in Alzheimer\u2019s Disease. Front Neurosci 9:. https:\/\/doi.org\/10.3389\/fnins.2015.00340","key":"602_CR40","DOI":"10.3389\/fnins.2015.00340"},{"key":"602_CR41","doi-asserted-by":"publisher","first-page":"E1230","DOI":"10.1073\/pnas.1320192111","volume":"111","author":"G Joshi","year":"2014","unstructured":"Joshi G, Chi Y, Huang Z, Wang Y (2014) A\u03b2-induced golgi fragmentation in Alzheimer\u2019s disease enhances A\u03b2 production. Proc Natl Acad Sci U S A 111:E1230\u2013E1239. https:\/\/doi.org\/10.1073\/pnas.1320192111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"602_CR42","doi-asserted-by":"publisher","first-page":"113481","DOI":"10.1016\/j.bbr.2021.113481","volume":"414","author":"R Cai","year":"2021","unstructured":"Cai R, Wang Y, Huang Z et al (2021) Role of RhoA\/ROCK signaling in Alzheimer\u2019s disease. Behav Brain Res 414:113481. https:\/\/doi.org\/10.1016\/j.bbr.2021.113481","journal-title":"Behav Brain Res"},{"key":"602_CR43","doi-asserted-by":"publisher","first-page":"102960","DOI":"10.1016\/j.bioorg.2019.102960","volume":"88","author":"JB Shaik","year":"2019","unstructured":"Shaik JB, Yeggoni DP, Kandrakonda YR et al (2019) Synthesis and biological evaluation of flavone-8-acrylamide derivatives as potential multi-target-directed anti alzheimer agents and investigation of binding mechanism with acetylcholinesterase. Bioorg Chem 88:102960. https:\/\/doi.org\/10.1016\/j.bioorg.2019.102960","journal-title":"Bioorg Chem"},{"key":"602_CR44","doi-asserted-by":"publisher","first-page":"5608","DOI":"10.3390\/ijms14035608","volume":"14","author":"M Bajda","year":"2013","unstructured":"Bajda M, Wieckowska A, Hebda M et al (2013) Structure-Based search for new inhibitors of cholinesterases. Int J Mol Sci 14:5608\u20135632. https:\/\/doi.org\/10.3390\/ijms14035608","journal-title":"Int J Mol Sci"},{"key":"602_CR45","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1021\/acs.jcim.7b00452","volume":"57","author":"S Hou","year":"2017","unstructured":"Hou S, Gu R-X, Wei D-Q (2017) Inhibition of \u03b2-Amyloid channels with a drug candidate wgx-50 revealed by molecular dynamics simulations. J Chem Inf Model 57:2811\u20132821. https:\/\/doi.org\/10.1021\/acs.jcim.7b00452","journal-title":"J Chem Inf Model"},{"doi-asserted-by":"publisher","unstructured":"L\u00fchrs T, Ritter C, Adrian M, et al (2005) 3D structure of Alzheimer\u2019s amyloid-\u03b2(1\u201342) fibrils. Proceedings of the National Academy of Sciences 102:17342\u201317347. https:\/\/doi.org\/10.1073\/pnas.0506723102","key":"602_CR46","DOI":"10.1073\/pnas.0506723102"},{"doi-asserted-by":"publisher","unstructured":"Ahmed M, Davis J, Aucoin D, et al (2010) Structural conversion of neurotoxic amyloid-\u03b2(1\u201342) oligomers to 7fibrils. Nat Struct Mol Biol 17:561\u2013567. https:\/\/doi.org\/10.1038\/nsmb.1799","key":"602_CR47","DOI":"10.1038\/nsmb.1799"},{"key":"602_CR48","doi-asserted-by":"publisher","first-page":"15436","DOI":"10.1021\/bi0204185","volume":"41","author":"ON Antzutkin","year":"2002","unstructured":"Antzutkin ON, Leapman RD, Balbach JJ, Tycko R (2002) Supramolecular structural constraints on Alzheimer\u2019s beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance. Biochemistry 41:15436\u201315450. https:\/\/doi.org\/10.1021\/bi0204185","journal-title":"Biochemistry"},{"key":"602_CR49","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1073\/pnas.222681699","volume":"100","author":"G Bitan","year":"2003","unstructured":"Bitan G, Kirkitadze MD, Lomakin A et al (2003) Amyloid \u03b2-protein (A\u03b2) assembly: A\u03b240 and A\u03b242 oligomerize through distinct pathways. Proc Natl Acad Sci U S A 100:330\u2013335. https:\/\/doi.org\/10.1073\/pnas.222681699","journal-title":"Proc Natl Acad Sci U S A"},{"key":"602_CR50","doi-asserted-by":"publisher","first-page":"17345","DOI":"10.1073\/pnas.0408153101","volume":"101","author":"B Urbanc","year":"2004","unstructured":"Urbanc B, Cruz L, Yun S et al (2004) In Silico study of amyloid \u03b2-protein folding and oligomerization. Proc Natl Acad Sci U S A 101:17345\u201317350. https:\/\/doi.org\/10.1073\/pnas.0408153101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"602_CR51","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1021\/acs.jctc.7b00028","volume":"13","author":"K Sargsyan","year":"2017","unstructured":"Sargsyan K, Grauffel C, Lim C (2017) How molecular size impacts RMSD applications in molecular dynamics simulations. J Chem Theory Comput 13:1518\u20131524. https:\/\/doi.org\/10.1021\/acs.jctc.7b00028","journal-title":"J Chem Theory Comput"},{"key":"602_CR52","doi-asserted-by":"publisher","first-page":"9685","DOI":"10.3390\/ijms23179685","volume":"23","author":"H Ohashi","year":"2022","unstructured":"Ohashi H, Tsuji M, Oguchi T et al (2022) Combined treatment with Curcumin and ferulic acid suppressed the A\u03b2-Induced neurotoxicity more than Curcumin and ferulic acid alone. Int J Mol Sci 23:9685. https:\/\/doi.org\/10.3390\/ijms23179685","journal-title":"Int J Mol Sci"},{"key":"602_CR53","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/jnr.20025","volume":"75","author":"K Ono","year":"2004","unstructured":"Ono K, Hasegawa K, Naiki H, Yamada M (2004) Curcumin has potent anti-amyloidogenic effects for Alzheimer\u2019s \u03b2-amyloid fibrils in vitro. J Neurosci Res 75:742\u2013750. https:\/\/doi.org\/10.1002\/jnr.20025","journal-title":"J Neurosci Res"},{"key":"602_CR54","doi-asserted-by":"publisher","first-page":"11196","DOI":"10.1021\/acs.jpcb.5b03116","volume":"119","author":"H-M Fan","year":"2015","unstructured":"Fan H-M, Gu R-X, Wang Y-J et al (2015) Destabilization of Alzheimer\u2019s A\u03b242 protofibrils with a novel drug candidate wgx-50 by molecular dynamics simulations. J Phys Chem B 119:11196\u201311202. https:\/\/doi.org\/10.1021\/acs.jpcb.5b03116","journal-title":"J Phys Chem B"},{"key":"602_CR55","doi-asserted-by":"publisher","first-page":"11710","DOI":"10.1021\/jp901057w","volume":"113","author":"MF Masman","year":"2009","unstructured":"Masman MF, Eisel ULM, Csizmadia IG et al (2009) In Silico study of Full-Length amyloid \u0392 1\u2013\u200942 Tri- and Penta-Oligomers in solution. J Phys Chem B 113:11710\u201311719. https:\/\/doi.org\/10.1021\/jp901057w","journal-title":"J Phys Chem B"},{"key":"602_CR56","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1529\/biophysj.106.100404","volume":"92","author":"N-V Buchete","year":"2007","unstructured":"Buchete N-V, Hummer G (2007) Structure and dynamics of parallel \u03b2-Sheets, hydrophobic core, and loops in Alzheimer\u2019s A\u03b2 fibrils. Biophys J 92:3032\u20133039. https:\/\/doi.org\/10.1529\/biophysj.106.100404","journal-title":"Biophys J"},{"key":"602_CR57","doi-asserted-by":"publisher","first-page":"14179","DOI":"10.1038\/s41598-023-40818-x","volume":"13","author":"M Rahimi","year":"2023","unstructured":"Rahimi M, Taghdir M, Abasi Joozdani F (2023) Dynamozones are the most Obvious sign of the evolution of conformational dynamics in HIV-1 protease. Sci Rep 13:14179. https:\/\/doi.org\/10.1038\/s41598-023-40818-x","journal-title":"Sci Rep"},{"key":"602_CR58","doi-asserted-by":"publisher","first-page":"36920","DOI":"10.1039\/d0ra06565j","volume":"10","author":"H Ali","year":"2020","unstructured":"Ali H, Allam A, Abu-Baih D et al (2020) Isolation and characterization of novel acetylcholinesterase inhibitors from Ficus benghalensis L. leaves \u2020. RSC Adv 10:36920. https:\/\/doi.org\/10.1039\/d0ra06565j","journal-title":"RSC Adv"},{"doi-asserted-by":"publisher","unstructured":"Sharma M, Thakur S, Jadhav H, Bharate S (2023) Identification of azelastine and carvedilol as cholinesterase inhibitors via Structure-Based virtual screening of FDA\u2010approved drugs. ChemistrySelect 8. https:\/\/doi.org\/10.1002\/slct.202301879","key":"602_CR59","DOI":"10.1002\/slct.202301879"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00602-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00602-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00602-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:57:06Z","timestamp":1762451826000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00602-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["602"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00602-7","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"type":"print","value":"0920-654X"},{"type":"electronic","value":"1573-4951"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"12 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"24"}}